Ethyl 4-fluoropyrazolo[1,5-a]pyridine-3-carboxylate, 97%, 250mg

1-Phenyl-2-pyrimidin-4-yl ethanone, 95.0%, 1g

Triethylammonium Acetate (2.0mol/L in Water) [for HPLC]100mL

6-Nitrophthalide>95.0%(GC)5g

Colonne capillaire GC ROTI®Cap-5, 25 m, 0,20 mm, 0,35 µm, 1 pièce(s)

1-BROMO-2-CHLORO-5-METHYL-4-NITROBENZENE, 95.0%, 50g

8-Methyl-5-(trifluoromethyl)quinolin-2(1H)-one, 97%, 5g

100 ml Tall Boston Round - PET - transparent - 24/410

2,2'-(Methylimino)bis(N,N-di-n-octylacetamide)>95.0%(GC)(T)1mL

(6-((1-(tert-Butyl)-1H-pyrazol-5-yl)amino)pyrazin-2-yl)methanol, 95+%, 2g

5-Fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]indazole-3-carboxylic acid, 97%, 1g

3-Fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 97.0%, 5g

2,3-dihydro-1,4-benzodioxin-6-ylhydrazine hydrochloride, 95.0%, 1g